Shopping Cart
Remove All
Your shopping cart is currently empty
NSC 625987 is a selective, high-affinity CDK4 inhibitor with an IC50 of 0.2 μM for CDK4:cyclin D1. Its selectivity for CDK4 is >500-fold greater than for CDK2, making it suitable for studying p16-associated tumors.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 2 mg | $113 | 5 days | 5 days | |
| 50 mg | $764 | 6-8 weeks | 6-8 weeks | |
| 100 mg | $1,190 | 6-8 weeks | 6-8 weeks |
| Description | NSC 625987 is a selective, high-affinity CDK4 inhibitor with an IC50 of 0.2 μM for CDK4:cyclin D1. Its selectivity for CDK4 is >500-fold greater than for CDK2, making it suitable for studying p16-associated tumors. |
| Targets&IC50 | CDK4/CyclinD1:0.2 μM |
| Synonyms | NSC-625987, NSC625987 |
| Molecular Weight | 271.33 |
| Formula | C15H13NO2S |
| Cas No. | 141992-47-4 |
| Smiles | S=C1C=2C=CC=CC2NC=3C(OC)=CC=C(OC)C13 |
| Relative Density. | 1.32g/cm3 |
| Storage | keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | Ethanol: <1 mg/mL DMSO: 80 mg/mL (294.84 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween-80+45% Saline: 1 mg/mL (3.69 mM), Sonication is recommeded. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.